Epigenetic cancer therapies: DNA methyltransferase inhibitors

R Brown, G Strathdee - Expert Opinion on Investigational Drugs, 2002 - Taylor & Francis
Human cancers frequently show altered patterns of DNA methylation, particularly at CpG
islands. These CpG islands are sequences of DNA rich in CpG dinucleotides and are often …
被引用次数：61 相关文章

Epigenetic cancer therapies: DNA methyltransferase inhibitors

G Strathdee, R Brown - Expert opinion on investigational …, 2002 - pubmed.ncbi.nlm.nih.gov
Human cancers frequently show altered patterns of DNA methylation, particularly at CpG
islands. These CpG islands are sequences of DNA rich in CpG dinucleotides and are often …

Epigenetic cancer therapies: DNA methyltransferase inhibitors

G Strathdee, R Brown - Expert Opinion on Investigational Drugs, 2002 - eprints.ncl.ac.uk
Human cancers frequently show altered patterns of DNA methylation, particularly at CpG
islands. These CpG islands are sequences of DNA rich in CpG dinucleotides and are often …

Epigenetic cancer therapies: DNA methyltransferase inhibitors.

G Strathdee, R Brown - Expert Opinion on Investigational Drugs, 2002 - europepmc.org
Human cancers frequently show altered patterns of DNA methylation, particularly at CpG
islands. These CpG islands are sequences of DNA rich in CpG dinucleotides and are often …

[引用][C] Epigenetic cancer therapies: DNA methyltransferase inhibitors.

R Brown - Expert Opinion on Investigational Drugs, 2002 - eprints.gla.ac.uk
Epigenetic cancer therapies: DNA methyltransferase inhibitors. - Enlighten Publications Skip to
main content Accessibility information Site navigation Study Research About us Student life …